Exergen Corporation and GE Healthcare, a unit of General Electric Company, have recently entered into an agreement for non-exclusive global distribution of Exergen’s model TAT-5000, the professional version of Exergen’s award winning TemporalScanner™ Temporal Artery Thermometer. Concurrently, Exergen and GE Healthcare have launched a joint development program to combine the technologies of temporal artery thermometry and vital signs monitoring.
With over 25 years of blood pressure monitoring experience and over 350,000 devices, GE Healthcare’s line of vital signs monitors provide more than 3 million vital signs determinations each day. With more than 1 million consumer and professional models in service, Exergen’s TemporalScanner™ Temporal Artery Thermometer has become the gold standard for accurate non-invasive temperature determination, providing nearly 1 million temperature measurements per day.
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Their expertise in medical
imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.
Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.
Exergen Corporation is an internationally respected innovator and leading manufacturer of an extensive line of patented infrared thermometers, scanners, sensors and controls used in a wide variety of industrial and medical applications for professional and consumer use. Founded by Harvard research scientist Francesco Pompei, Ph.D. nearly three decades ago in Boston, MA, the company continues to lead the way in its field by providing highly accurate results, with less invasiveness, greater comfort, and lower cost, and than with any other thermometry methods.
For more information, visit www.exergen.com.
Public Relations Contact: Rosica Strategic Public Relations